The Trendlines Group (SGX:42T) said its board and audit committee approved investments by related companies of Librae Holdings in its portfolio firms, according to a Friday filing on the Singapore Exchange.

The Librae-related companies, ultimately owned by a trust benefiting British businessman Vincent Tchenguiz, will invest a total of $2.2 million across four Trendlines-backed firms, while Trendlines itself will contribute $850,000.

Trendlines said the investments include $350,000 in Arcuro Medical, $600,000 in IBI AG, $600,000 in Ceretrieve, and $600,000 in Celleste Bio.

The funding will be structured as either share purchase agreements or Simple Agreements for Future Equity (SAFE).